Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549

Acta Pharmacologica Sinica

Volumn 32, Issue 11, 2011, Pages 1397-1401

  Ye, Bin ^a   Xie, Yan ^a   Qin, Zheng Hong ^b   Wu, Jun Chao ^b   Han, Rong ^b   He, Jing Kang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

angiogenesis; apoptosis; caspase 3; cell cycle; crotoxin (CrTX); human lung adenocarcinoma; P38MAPK; p53

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CROTOXIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CROTALUS; CROTOXIN; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80755163133     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.116     Document Type: Article

References (21)

1. Kattah LR, Ferraz V, Matos Santoro M, Ribeiro da Silva Camargos E, Ribeiro Diniz C, De Lima ME. Analysis of fatty acids released by crotoxin in rat brain synap twosomes. Toxicon 2002; 40: 43-9. (Pubitemid 32972055)
2. Picolo G, Cury Y. Peripheral neuronal nitric oxide synthase activity mediates antinociceptive effect of Crotalus durissus snake venom, a delta and kappa opioid receptor agonist. Life Sci 2004; 75: 559-73. (Pubitemid 38670263)
3. Yan CH, Liang ZQ, Gu ZL, Yang YP, Reid P, Qin ZH. Contributions of autophagic and apoptotic mechanisms to CrTX-induced death of K562 cells. Toxicon 2006; 47: 521-30.
4. Penzo D, Petronilli V, Angelin A, Cusan C, Colonna R, Scorrano L, et al. Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway. J Biol Chem 2004; 279: 25219-25. (Pubitemid 38756773)
5. Donato NJ, Martin CA, Perez M, Newman RA, Vidal JC, Etcheverry M. Regulation of epidermal growth factor receptor activity by CrTX, a snake venom phospholipase A2 toxin. Biochem Pharmacol 1996; 51: 1535-42
6. Dempke WC, Suto T, Reck M. Targeted therapies for non-small cell lung cancer. Lung Cancer 2010; 67: 257-74.
7. Collins DM, Crown J, O'Donovan N, Devery A, O'Sullivan F, O'Driscoll L, et al. Tyrosine kinase inhibitors potentiate the cytotoxicity of MDRsubstrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. Invest New Drugs 2010; 28: 433-44.
8. Newman RA, Vidal JC, Viskatis LJ, Johnson J, Etcheverry MA. VRCTC- 310-a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity. Invest New Drugs 1993; 11: 151-9. (Pubitemid 23277235)
9. Ellinger-Ziegelbauer H, Kelly K, Siebenlist U. Cell cycle arrest and reversion of Ras induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol Cell Biol 1999; 19: 3857-68. (Pubitemid 29193845)
10. Maj JG, Kankofer M. Activity of 72-kDa and 92-kDa matrix metalloproteinases in placental tissues of cows with and without retained fetal membranes. Placenta 1997; 18: 683-7. (Pubitemid 27448426)
11. Ichijo H. From receptor to stress-activated MAP kinases. Oncogene 1999; 18: 6087-93.
12. Martin-Blanco E. p38MAPK signalling cascades: ancient roles and new function. Bioessays 2000; 22: 637-45.
13. Ono k, Han J. The p38 signal transduction pathway: activation and function. Cell Signal 2000; 12: 1-13. (Pubitemid 30017963)
14. Tawa P, Hell K, Giroux A, Grimm E, Han Y, Nicholson DW, et al. Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors. Cell Death Differ 2004; 11: 439-47. (Pubitemid 38489421)
15. An S, Park MJ, Park IC, Hong SI, Knox K. Procaspase-3 and its active large subunit localized in both cytoplasm and nucleus are activated following application of apoptotic stimulus in Ramos-Burkitt lymphoma B cells. Int J Mol Med 2003; 12: 311-7.
16. Yan CH, Yang YP, Qin ZH, Gu ZL, Reid P, Liang ZQ. Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells. Acta Pharmacol Sin 2007; 28: 540-8 (Pubitemid 46496084)
17. Kim KW, Kim BJ, Chung CW, Jo DG, Kim IK, Song YH, et al. Caspase cleavage product lacking amino-terminus of Ikappa Balpha sensitizes resistant cells to TNF-alpha and TRALL induced apoptosis. J Cell Biochem 2002; 85: 334-45. (Pubitemid 34274901)
18. Lee JC, Kassis S, Kumar S. p38Mitogen-activated protein kinase inhibitors mechanisms and therapeutic potentials. Pharmacol Ther 1999; 82: 389-97. (Pubitemid 29255932)
19. Vogelstein B, Lane D, Levine AJ. Surfing the P53 network. Nature 2000; 408: 307-10.
20. Su JC, Lin KL, Chien CM, Lu CM, Chen YL, Chang LS, et al. Novel indoloquinoline derivative, IQDMA, induces G2/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation. Life Sci 2009; 85: 505-16.
21. Yang PM, Huang WC, Lin YC, Huang WY, Wu HA, Chen WL, et al. Loss of IKKbeta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis. J Cell Mol Med 2010; 14: 687-98.